Page 138 - EJMO-9-2

Eurasian Journal of Medicine and
Oncology
Anticancer effects of phytocomposites

Clearing the way for cancer cell invasion. Ann Transl Med. doi: 10.3892/etm.2021.10762
2020;8(14):902.
77. Mohan V, Agarwal R, Singh RP. A novel alkaloid, evodiamine
doi: 10.21037/atm.2020.02.157 causes nuclear localization of cytochrome-c and induces
67. Windham TC, Parikh NU, Siwak DR, et al. Src activation apoptosis independent of p53 in human lung cancer cells.
regulates anoikis in human colon tumor cell lines. Oncogene. Biochem Biophys Res Commun. 2016;477(4):1065-1071.
2002;21(51):7797-7807. doi: 10.1016/j.bbrc.2016.07.037
doi: 10.1038/sj.onc.1205989 78. Hong Z, Wang Z, Zhou B, et al. Effects of evodiamine on
68. Playford MP, Schaller MD. The interplay between Src PI3K/Akt and MAPK/ERK signaling pathways in pancreatic
and integrins in normal and tumor biology. Oncogene. cancer cells. Int J Oncol. 2020;56:783-793.
2004;23(48):7928-7946. doi: 10.3892/ijo.2020.4956
doi: 10.1038/sj.onc.1208080 79. Ogasawara M, Matsunaga T, Takahashi S, Saiki I, Suzuki H.
69. Leong HS, Robertson AE, Stoletov K, et al. Invadopodia are Anti-invasive and metastatic activities of evodiamine. Biol
required for cancer cell extravasation and are a therapeutic Pharm Bull. 2002;25(11):1491-1493.
target for metastasis. Cell Rep. 2014;8(5):1558-1570. doi: 10.1248/bpb.25.1491
doi: 10.1016/j.celrep.2014.07.050 80. Yu H, Jin H, Gong W, Wang Z, Liang H. Pharmacological
70. Eckert MA, Lwin TM, Chang AT, et al. Twist1-induced actions of multi-target-directed evodiamine. Molecules.
invadopodia formation promotes tumor metastasis. Cancer 2013;18(2):1826-1843.
Cell. 2011;19(3):372-386. doi: 10.3390/molecules18021826
doi: 10.1016/j.ccr.2011.01.036 81. Ren L, Lou Y, Sun M. The anti-tumor effects of evodiamine
71. Campone M, Bondarenko I, Brincat S, et al. Phase II study on oral squamous cell carcinoma (OSCC) through
of single-agent bosutinib, a Src/Abl tyrosine kinase inhibitor, regulating advanced glycation end products (AGE)/receptor
in patients with locally advanced or metastatic breast cancer for advanced glycation end products (RAGE) pathway.
pretreated with chemotherapy. Ann Oncol. 2011;23(3):610-617. Bioengineered. 2021;12(1):5985-5995.
doi: 10.1093/annonc/mdr261 doi: 10.1080/21655979.2021.1972082
72. Gucalp A, Sparano JA, Caravelli J, et al. Phase II trial of 82. Lin L, Lv S, Ren H, et al. Evodiamine inhibits EPRS expression
saracatinib (AZD0530), an Oral SRC-inhibitor for the treatment to regulate glutamate metabolism and proliferation of
of patients with hormone receptor-negative metastatic breast oral squamous cell carcinoma cells. Kaohsiung J Med Sci.
cancer. Clin Breast Cancer. 2011;11(5):306-311. 2024;40(4):348-359.
doi: 10.1016/j.clbc.2011.03.021 doi: 10.1002/kjm2.12803
73. Mackay HJ, Au HJ, McWhirter E, et al. A phase II trial of the 83. Ma Y, Liu Y, Wang Y, et al. The nanocomposite system
Src kinase inhibitor saracatinib (AZD0530) in patients with comprising folic acid-modified graphene quantum dots
metastatic or locally advanced gastric or Gastro Esophageal loaded with evodiamine in the treatment of oral squamous
Junction (GEJ) adenocarcinoma: A trial of the PMH phase cell carcinoma. Mater Des. 2022;220:110838.
II consortium. Invest New Drugs. 2011;30(3):1158-1163.
doi: 10.1016/j.matdes.2022.110838
doi: 10.1007/s10637-011-9650-4
84. Ma XN, Xie CL, Miao Z, Yang Q, Yang XW. An overview
74. Lee S, Park S, Ryu JS, et al. c-Src inhibitor PP2 inhibits of chemical constituents from Alpinia species in the last six
head and neck cancer progression through regulation decades. RSC Adv. 2017;7(23):14114-14144.
of the epithelial-mesenchymal transition. Exp Biol Med
(Maywood). 2022;248(6):492-500. doi: 10.1039/c6ra27830b
doi: 10.1177/15353702221139183 85. Hua SZ, Luo JG, Wang XB, Wang JS, Kong LY. Two
novel monoterpene-chalcone conjugates isolated from
75. Min HY, Jung Y, Park KH, Oh WK, Lee HY. Erybraedin the seeds of Alpinia katsumadai. Bioorg Med Chem Lett.
A is a potential Src inhibitor that blocks the adhesion and 2009;19(10):2728-2730.
viability of non-small-cell lung cancer cells. Biochem Biophys
Res Commun. 2018;502(1):145-151. doi: 10.1016/j.bmcl.2009.03.117
doi: 10.1016/j.bbrc.2018.05.137 86. You HL, Zhou B, Guo MJ, et al. Monoterpene-chalcone
conjugates and diarylheptanoids isolated from the seeds
76. Luo C, Ai J, Ren E, et al. Research progress on evodiamine,
a bioactive alkaloid of Evodiae fructus: Focus on its anti- of Alpinia katsumadai hayata with cytotoxic activity.
cancer activity and bioavailability (Review). Exp Ther Med. Phytochemistry. 2024;225:114197.
2021;22(5):1327. doi: 10.1016/j.phytochem.2024.114197

Volume 9 Issue 2 (2025) 130 doi: 10.36922/ejmo.7073